000 01269 a2200337 4500
005 20250513192345.0
264 0 _c19990928
008 199909s 0 0 eng d
022 _a0090-4481
024 7 _a10.3928/0090-4481-19990801-08
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCanfield, S D
245 0 0 _aPrevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics).
_h[electronic resource]
260 _bPediatric annals
_cAug 1999
300 _a507-14 p.
_bdigital
500 _aPublication Type: Guideline; Journal Article
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulins
_xadministration & dosage
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
650 0 4 _aPalivizumab
650 0 4 _aRespiratory Syncytial Virus Infections
_ximmunology
650 0 4 _aRespiratory Syncytial Virus, Human
_ximmunology
700 1 _aSimoes, E A
773 0 _tPediatric annals
_gvol. 28
_gno. 8
_gp. 507-14
856 4 0 _uhttps://doi.org/10.3928/0090-4481-19990801-08
_zAvailable from publisher's website
999 _c10440983
_d10440983